• Forum
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Careium

24.60 SEK

-3.53 %

Less than 1K followers

CARE

First North Stockholm

Hardware Manufacturer

Technology

Overview
Financials & Estimates
Ownership
Dividend
Investor consensus
Compare
-3.53 %
+4.68 %
+23.93 %
+3.36 %
+2.07 %
-23.36 %
+74.47 %
-
-23.36 %

Careium offers security solutions such as security alarms, smart sensors and digital visits, with its own alarm center that is staffed 24/7. The product offering includes security alarms, sensors and accessories such as cameras and electronic locks. The company targets private individuals, municipalities and care organizations, and is active in several countries in Europe. The company is headquartered in Malmö, Sweden.

Read more
Market cap
598.42M SEK
Turnover
218.08K SEK
Revenue
854.1M
EBIT %
5.76 %
P/E
18.5
Dividend yield-%
-
Revenue and EBIT-%
EPS and dividend
Financial calendar
All
Webcasts
Press releases
3rd party
ShowingAll content types

Revenue and EBIT-%

Revenue M

EBIT-% (adj.)

EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
10/7
2026

Interim report Q2'26

22/10
2026

Interim report Q3'26

Third party research13 hours ago

Careium: Growth's necessary trade-off - ABG

* Q2e: 13% organic sales growth, 4.5% EBITA margin * We raise opex on increased competition * Trading at 11.5x '26e EV/EBITA Q2e will likely mirror Q1 We expect another strong quarter from Careium in terms of organic growth y-o-y due to the easy comps...

Careium
Regulatory press release5/12/2026, 2:45 PM

Careium skriver nationellt ramavtal med ADDA Sverige inom välfärdsteknik

Careium
Regulatory press release5/12/2026, 2:45 PM

Careium signs national framework agreement with Adda in Sweden for welfare technology

Careium

Join Inderes community

Don't miss out - create an account and get all the possible benefits

Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Create account
Third party research4/24/2026, 5:17 AM

Careium: Relief around the corner - ABG

* Underlying development looks promising * We raise our '26-'28 EBIT estimates by 3-1% * Share is trading at 10x-7x '26e-'28e EV/EBIT Margins not as soft as expected Q1 came in 2% (SEK 4m) above our expectations on sales, for a solid organic growth of...

Careium
Regulatory press release4/23/2026, 12:05 PM

Kommuniké från årsstämma i Careium AB (publ)

Careium
Regulatory press release4/23/2026, 12:05 PM

Report from Annual General Meeting in Careium AB (publ)

Careium
Third party research4/23/2026, 6:59 AM

Careium: Strong growth makes up for elevated costs - ABG

* Q1 sales 2% above our ests. at SEK 220m, for 11% org. growth * Adj. EBIT SEK 13m vs. ABGSCe 9m * Trading at 10x-7x '26e-'28e EV/EBITA adj. A strong Q1 given ongoing headwinds Q1 came in slightly above expectations on sales, and materially above expectations...

Careium
Regulatory press release4/23/2026, 6:00 AM

Careium rapporterar första kvartalet 2026

Careium
Regulatory press release4/23/2026, 6:00 AM

Careium reports first quarter results 2026

Careium
Press release4/9/2026, 6:00 AM

Inbjudan till presentation av Careiums delårsrapport för första kvartalet 2026

Careium
Press release4/9/2026, 6:00 AM

Invitation to presentation of Careium’s first quarter report 2026

Careium
Third party research4/2/2026, 5:23 AM

Careium: Entering a growth-focused period - ABG

* Q1e: 10% organic sales growth, 4% adj. EBITA margin * We cut our EBITA estimates by 7-2% * Trading at 9x '26e EV/EBITA Q1e: strong organic growth, but soft margins We expect Q1 to be strong in terms of organic growth, as Careium will no longer face...

Careium
Regulatory press release3/27/2026, 12:15 PM

Tove Christiansson tillträder som VD för Careium den 1 juni

Careium
Regulatory press release3/27/2026, 12:15 PM

Tove Christiansson joins as CEO of Careium on June 1

Careium
Regulatory press release3/25/2026, 1:45 PM

Careium publicerar årsredovisning med hållbarhetsrapport för 2025

Careium
Regulatory press release3/25/2026, 1:45 PM

Careium publishes Annual and Sustainability Report 2025

Careium
Regulatory press release3/20/2026, 7:00 AM

Kallelse till årsstämma i Careium AB (publ)

Careium
Regulatory press release3/20/2026, 7:00 AM

Notice of Annual General Meeting in Careium AB (publ)

Careium
Third party research2/12/2026, 6:28 AM

Careium: Bittersweet outlook on 2026 - ABG

* Margin pressure to remain in H1'26e * We cut our '26-'27 EBIT estimates by 15% and 9% * Share is trading at 9x-7x '26e-'27e EV/EBIT EBIT materially lower than anticipated Careium delivered solid sales in Q4, with organic growth of 6.3% despite tough...

Careium
Third party research2/11/2026, 9:22 AM

Careium: Margin pressure to remain in H1'26 - ABG

* Q4 sales 4% above our ests. at SEK 231m, for 6% org. growth * Adj. EBIT SEK 8m vs. ABGSCe 22m * Trading at 8x-7x '26e-'27e EV/EBITA adj. Solid sales but material opex growth Q4 came in above expectations on sales, but materially below on EBIT. Careium...

Careium